BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16356838)

  • 1. Expression of sFRP-4 and beta-catenin in human colorectal carcinoma.
    Feng Han Q; Zhao W; Bentel J; Shearwood AM; Zeps N; Joseph D; Iacopetta B; Dharmarajan A
    Cancer Lett; 2006 Jan; 231(1):129-37. PubMed ID: 16356838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
    Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
    Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair, p53 and beta-catenin proteins in colorectal cancer.
    Valentini AM; Renna L; Armentano R; Pirrelli M; Di Leo A; Gentile M; Caruso ML
    Anticancer Res; 2002; 22(4):2083-8. PubMed ID: 12174887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
    Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
    Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
    Lüchtenborg M; Weijenberg MP; Wark PA; Saritas AM; Roemen GM; van Muijen GN; de Bruïne AP; van den Brandt PA; de Goeij AF
    BMC Cancer; 2005 Dec; 5():160. PubMed ID: 16356174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced COX-2 protein in colorectal cancer with defective mismatch repair.
    Karnes WE; Shattuck-Brandt R; Burgart LJ; DuBois RN; Tester DJ; Cunningham JM; Kim CY; McDonnell SK; Schaid DJ; Thibodeau SN
    Cancer Res; 1998 Dec; 58(23):5473-7. PubMed ID: 9850081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
    Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
    J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.
    Lavergne E; Hendaoui I; Coulouarn C; Ribault C; Leseur J; Eliat PA; Mebarki S; Corlu A; Clément B; Musso O
    Oncogene; 2011 Jan; 30(4):423-33. PubMed ID: 20856206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.
    Pancione M; Forte N; Fucci A; Sabatino L; Febbraro A; Di Blasi A; Daniele B; Parente D; Colantuoni V
    Hum Pathol; 2010 Jun; 41(6):867-76. PubMed ID: 20129645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.
    Hendriks Y; Franken P; Dierssen JW; De Leeuw W; Wijnen J; Dreef E; Tops C; Breuning M; Bröcker-Vriends A; Vasen H; Fodde R; Morreau H
    Am J Pathol; 2003 Feb; 162(2):469-77. PubMed ID: 12547705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.
    Andachi H; Yashima K; Koda M; Kawaguchi K; Kitamura A; Hosoda A; Kishimoto Y; Shiota G; Ito H; Makino M; Kaibara N; Kawasaki H; Murawaki Y
    Br J Cancer; 2002 Aug; 87(4):441-5. PubMed ID: 12177781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
    Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
    Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The silence of the genes: matching mismatch repair defects with tumors.
    Boland CR; Goel A
    Cancer; 2003 Nov; 98(10):2091-4. PubMed ID: 14601077
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
    Suzuki H; Watkins DN; Jair KW; Schuebel KE; Markowitz SD; Chen WD; Pretlow TP; Yang B; Akiyama Y; Van Engeland M; Toyota M; Tokino T; Hinoda Y; Imai K; Herman JG; Baylin SB
    Nat Genet; 2004 Apr; 36(4):417-22. PubMed ID: 15034581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.